Pelvic & vaginal health

Sacral Neuromodulation: A Pacemaker for the Bladder

Save

InterStim is a sacral neuromodulation implant, a bladder pacemaker, for overactive bladder or non-obstructive retention that resists other care. Mild pulses to the sacral nerves steady bladder signaling. A trial-lead test comes first, and only people who clearly improve proceed to the permanent implant. It is a third-line, specialist-managed option.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is sacral neuromodulation?

Sacral neuromodulation is a treatment that steadies the nerve signals between the bladder and the brain using a small implanted device, and InterStim is one common brand name. The device sends gentle electrical pulses to the sacral nerves near the base of the spine, which help coordinate how the bladder stores and releases urine. It is used for an overactive bladder that keeps causing urgency and frequency, and for some cases of non-obstructive urinary retention. According to urinary-incontinence guidance, sacral neuromodulation is a recognized third-line therapy, meaning it follows behavioral steps and medication rather than replacing them 1. Roughly 1 in 4 women live with a bladder-control problem at some point in life 1.

How does the bladder pacemaker work?

The nickname pacemaker fits because the device continuously delivers low-level pulses to keep bladder signaling on a steadier rhythm, much as a heart pacemaker steadies heartbeat. Fine wires, called leads, rest near the sacral nerve roots, and a small battery-powered generator sits under the skin of the upper buttock. Newer systems are often rechargeable and can last about 10 to 15 years before replacement. Because it modulates the nerve conversation rather than the bladder muscle directly, it can help both urgency and certain retention, unlike drugs that push in only one direction. Pelvic floor training and bladder medication are still tried first, and Cochrane evidence supports pelvic floor training as an effective starting point 3.

What is the trial-lead step?

The trial-lead step is what makes sacral neuromodulation unusual: you get to test-drive the therapy before committing to a permanent implant. A clinician places a thin temporary lead near the sacral nerve, usually in an office or short outpatient visit, and you wear an external stimulator for about 1 to 2 weeks while tracking symptoms. People are typically offered the permanent implant only if they see a clear improvement, often about a 50% reduction in symptoms, during that test. This built-in trial spares people who would not benefit from an unnecessary implant. Pelvic floor training started around pregnancy and continued postpartum can lower later incontinence, so conservative care matters at every stage 5.

Who is InterStim for, and does it work?

Sacral neuromodulation is aimed at people whose overactive bladder or non-obstructive retention has not eased with lifestyle changes, pelvic floor work, medication, and sometimes office-based tibial nerve stimulation. Many people who pass the trial report substantial, durable improvement, though it is a therapy to manage rather than a one-time cure, and the device may need adjustments over time. A systematic review of nonsurgical and device options supports its role for refractory symptoms 2. Overactive bladder grows more common with age and after menopause, when falling estrogen affects the bladder and urethra, part of genitourinary syndrome of menopause described by the North American Menopause Society 4. Candidates also weigh imaging compatibility, since some older devices limit certain MRI scans.

When refractory bladder symptoms need a specialist

Bladder symptoms that persist despite pelvic floor physical therapy, behavioral changes, and medication are the point to ask about advanced options like sacral neuromodulation. A urogynecologist or urologist confirms the diagnosis, rules out infection or a treatable blockage, and explains the trial-first path so you can decide with clear expectations. According to professional guidelines, these third-line therapies are reserved for genuinely refractory symptoms, not first attempts 1. Because the trial step tests benefit before any permanent device, it lowers the stakes of trying. Gale can help you prepare for that specialist conversation and gather the symptom history that makes it productive.

Common questions

Both are neuromodulation for overactive bladder, but they differ in setup. PTNS uses a needle near the ankle during repeat office visits and implants nothing. InterStim places a small permanent device near the sacral nerves after a successful trial. InterStim is usually considered for symptoms that have resisted other treatments, including PTNS.

A clinician places a temporary lead near the sacral nerve, and you wear an external stimulator for roughly one to two weeks while tracking symptoms. If you see a clear improvement, often about a 50% reduction in symptoms, you may proceed to the permanent implant. If not, the lead is removed and no device is placed.

The device is meant to stay in place long-term, but it can be turned off, adjusted, or removed if needed. Batteries are replaced when they run down, and many newer systems are rechargeable and last years. It is a therapy to manage over time rather than a single fix, with periodic check-ins.

It depends on the specific device. Many newer sacral neuromodulation systems are approved as MRI-conditional, meaning scans are possible under set conditions, while some older models limit certain scans. Your care team records your device details so imaging can be planned safely. Always mention the implant before any MRI.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Refractory bladder symptoms: when to seek care

  • Bladder symptoms that persist despite behavioral steps, pelvic floor therapy, and medication are a reason to seek specialist review
  • Blood in the urine, or urgency with fever and back or flank pain, is a reason to seek prompt clinician review
  • Sudden inability to pass urine with a painful, swollen lower belly is a reason to seek same-day or emergency care
  • New pain, swelling, redness, or drainage at the implant or lead site is a reason to seek clinician review

Sudden inability to pass any urine with a painful or swollen lower belly can be acute urinary retention: seek same-day care or go to an emergency room right away.

This article is general health education, not medical advice. Whether sacral neuromodulation is appropriate is decided with a urogynecologist or urologist based on your diagnosis and history.

References

  1. 1.American College of Obstetricians and Gynecologists (2015). ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001148Identifies sacral neuromodulation as a recognized third-line therapy for overactive bladder and non-obstructive retention after behavioral and pharmacologic steps, and reports bladder-control problems affect about a quarter of women.
  2. 2.Balk E, Adam GP, Kimmel H, Rofeberg V, Saeed I, Jeppson P, Trikalinos T (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. Agency for Healthcare Research and Quality (AHRQ). PMID 30516945Systematic review of nonsurgical treatments for urinary incontinence in women, supporting a stepwise order and a role for device therapies in refractory symptoms.
  3. 3.Dumoulin C, Cacciari LP, Hay-Smith EJC (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005654.pub4Cochrane review supporting pelvic floor muscle training as an effective first-line treatment for urinary incontinence in women.
  4. 4.The North American Menopause Society (Menopause Society) (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000001609Describes genitourinary syndrome of menopause, in which declining estrogen affects the bladder and urethra and can worsen urgency after menopause.
  5. 5.Woodley SJ, Lawrenson P, Boyle R, et al. (2020). Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD007471.pub4Cochrane review showing pelvic floor muscle training around pregnancy and the postpartum period can reduce later urinary incontinence.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy